L-perillyl alcohol, alpha-linolenic acid, ao shiso, apigenin, baisu, ban tulsi (Bengali), beefsteak plant, bhanjira (Hindi), caffeic acid, Chinese basil, chi-ssu (Chinese), common perilla, d-limonene, dihydroperillic acid, egoma (Japanese), hung-sha-yao (Chinese), ji soo, kkaennip namul (Korean), Labiatae (family), Lamiaceae (family), limonene, luteolin, m-hydroxyphenylpropionic acid, methyl caffeate, monoterpene, monoterpene perillyl alcohol, perilla seed oil, perilla seed perillaldehyde, perilla oil, perillic acid, perilloside A, perilloside C, perillyl alcohol, Perilla frutescens, purple mint, purple perilla, rattlesnake weed, red perilla, rosmarinic acid, trans-caffeic acid, shiso (Japanese), shisonoha (Japanese, red leaved form), summer coleus, trans-carveol, trans-m-coumaric acid, ts'ao-t'ou (Chinese), tsu-shih ts'ao (Chinese), tzu ssu (Chinese), wild basil, wild coleus, wild red basil, yeh-ssu (Chinese), zisu.
Perilla is a traditional crop of China, India, Japan, Korea, Thailand, and other Asian countries. In North America, it is occasionally called by its Japanese name, shiso. In North America, it is also known as purple mint, Chinese basil, or wild coleus. Perilla seed oil is used for cooking, as a drying oil, and as a fuel. Perilla seed oil is high in the omega-3 fatty acid, alpha-linolenic acid.
Some evidence is available for the use of perilla oil for reduction in asthma symptoms, as well as use of perilla extract for seasonal allergies. More clinical evidence is required before recommendations can be made for any clinical usage of perilla.
Preliminary evidence suggests some benefit of perilla extract for seasonal allergies. Further clinical trials are required before a firm recommendation can be made.
Aphthous stomatitis (mouth ulcer or canker sore):
Preliminary evidence suggests there is no benefit of perilla oil over soybean oil for aphthous stomatitis prevention. Further clinical trials are required before a firm recommendation can be made.
Preliminary evidence suggests some benefit of perilla oil for symptoms of asthma. Further clinical trials are required before a firm recommendation can be made.